Oxidative metabolism of endocannabinoids.

There is increasing evidence that endocannabinoids play roles in a number of physiological and pathological processes ranging from the regulation of food intake to the inhibition of cancer cell proliferation. Consequently, multiple investigations into endocannabinoid metabolic disposition have been initiated. Such studies have begun to shed light on the mechanisms that regulate the endogenous cannabinoid system. In addition, they have identified a number of novel, endocannabinoid-derived lipids. In the future, these studies may form the foundation of efforts designed to subtly manipulate endocannabinoid tone in vivo to achieve therapeutic benefits without the profound side-effects observed with synthetic cannabinoid treatment. In addition to the well-studied hydrolytic mode of endocannabinoid metabolism, accumulating data suggest that these lipids are also susceptible to oxidative metabolism by a number of fatty acid oxygenases. These include the cyclooxygenases, lipoxygenases, and cytochrome P450s known to be involved in eicosanoid production from arachidonic acid. The available evidence concerning endocannabinoid oxidation is reviewed and the potential biological significance of this mode of metabolism is considered.

[1]  J. Walker,et al.  Identification of a New Class of Molecules, the Arachidonyl Amino Acids, and Characterization of One Member That Inhibits Pain* , 2001, The Journal of Biological Chemistry.

[2]  J. Morrow,et al.  Metabolism of Prostaglandin Glycerol Esters and Prostaglandin Ethanolamides in Vitro and in Vivo * , 2001, The Journal of Biological Chemistry.

[3]  L. Marnett,et al.  Amino Acid Determinants in Cyclooxygenase-2 Oxygenation of the Endocannabinoid 2-Arachidonylglycerol* , 2001, The Journal of Biological Chemistry.

[4]  B. Cravatt,et al.  Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[5]  J. Falck,et al.  The CYP P450 arachidonic acid monooxygenases: from cell signaling to blood pressure regulation. , 2001, Biochemical and biophysical research communications.

[6]  R. Lai,et al.  The pharmacology of bimatoprost (Lumigan). , 2001, Survey of ophthalmology.

[7]  L. Marnett,et al.  Selective oxygenation of the endocannabinoid 2-arachidonylglycerol by leukocyte-type 12-lipoxygenase. , 2001, Biochemistry.

[8]  K. Waku,et al.  2-Arachidonoylglycerol and the cannabinoid receptors. , 2000, Chemistry and physics of lipids.

[9]  S. Goparaju,et al.  Endocannabinoids as cardiovascular modulators. , 2000, Chemistry and physics of lipids.

[10]  L. Petrocellis,et al.  Endocannabinoids and fatty acid amides in cancer, inflammation and related disorders. , 2000, Chemistry and physics of lipids.

[11]  D. Piomelli,et al.  The endocannabinoid system: a physiological perspective on its role in psychomotor control. , 2000, Chemistry and physics of lipids.

[12]  A. Howlett,et al.  Cellular signal transduction by anandamide and 2-arachidonoylglycerol. , 2000, Chemistry and physics of lipids.

[13]  L. Marnett,et al.  Oxygenation of the Endocannabinoid, 2-Arachidonylglycerol, to Glyceryl Prostaglandins by Cyclooxygenase-2* , 2000, The Journal of Biological Chemistry.

[14]  T. Bisogno,et al.  Comparative biology of the endocannabinoid system possible role in the immune response. , 2000, European journal of biochemistry.

[15]  C. Hillard Endocannabinoids and vascular function. , 2000, The Journal of pharmacology and experimental therapeutics.

[16]  B. Yagen,et al.  Oxidative metabolism of anandamide. , 2000, Prostaglandins & other lipid mediators.

[17]  L. Petrocellis,et al.  Cannabimimetic fatty acid derivatives in cancer and inflammation. , 2000, Prostaglandins & other lipid mediators.

[18]  S. Yamamoto,et al.  Anandamide amidohydrolase (fatty acid amide hydrolase). , 2000, Prostaglandins & other lipid mediators.

[19]  J. Falck,et al.  Cytochrome P450 and arachidonic acid bioactivation. Molecular and functional properties of the arachidonate monooxygenase. , 2000, Journal of lipid research.

[20]  L. Petrocellis,et al.  Cannabimimetic fatty acid derivatives: the anandamide family and other endocannabinoids. , 1999, Current medicinal chemistry.

[21]  V. Marzo Biosynthesis and inactivation of endocannabinoids: relevance to their proposed role as neuromodulators. , 1999 .

[22]  T. Bisogno,et al.  Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function. , 1999, Biochemical and biophysical research communications.

[23]  K. Abouzid,et al.  Substrate specificity and stereoselectivity of rat brain microsomal anandamide amidohydrolase. , 1999, Journal of medicinal chemistry.

[24]  M. Maccarrone,et al.  Anandamide Hydrolysis by Human Cells in Culture and Brain* , 1998, The Journal of Biological Chemistry.

[25]  H. Kuhn,et al.  Probing the substrate alignment at the active site of 15-lipoxygenases by targeted substrate modification and site-directed mutagenesis. Evidence for an inverse substrate orientation. , 1998, Biochemistry.

[26]  P. Lipsky,et al.  Cyclooxygenase in biology and disease , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[27]  J. Falck,et al.  Human platelets and polymorphonuclear leukocytes synthesize oxygenated derivatives of arachidonylethanolamide (anandamide): their affinities for cannabinoid receptors and pathways of inactivation. , 1998, Molecular pharmacology.

[28]  D. Swinney,et al.  The Dynamics of Prostaglandin H Synthases , 1998, The Journal of Biological Chemistry.

[29]  S. Yamamoto,et al.  Anandamide amidohydrolase reacting with 2‐arachidonoylglycerol, another cannabinoid receptor ligand , 1998, FEBS letters.

[30]  C. Ramesha,et al.  Synthesis of Prostaglandin E2 Ethanolamide from Anandamide by Cyclooxygenase-2* , 1997, The Journal of Biological Chemistry.

[31]  D. Piomelli,et al.  A second endogenous cannabinoid that modulates long-term potentiation , 1997, Nature.

[32]  S. Dey,et al.  Changes in anandamide levels in mouse uterus are associated with uterine receptivity for embryo implantation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[33]  H. Homma,et al.  Liquid chromatographic-atmospheric pressure chemical ionization mass spectrometric determination of anandamide and its analogs in rat brain and peripheral tissues. , 1997, Journal of chromatography. B, Biomedical sciences and applications.

[34]  Z. Vogel,et al.  Structural requirements for binding of anandamide-type compounds to the brain cannabinoid receptor. , 1997, Journal of medicinal chemistry.

[35]  W. A. Hill,et al.  Anandamide hydroxylation by brain lipoxygenase:metabolite structures and potencies at the cannabinoid receptor. , 1995, Biochimica et biophysica acta.

[36]  N. Ueda,et al.  Partial Purification and Characterization of the Porcine Brain Enzyme Hydrolyzing and Synthesizing Anandamide (*) , 1995, The Journal of Biological Chemistry.

[37]  A. Yamashita,et al.  2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. , 1995, Biochemical and biophysical research communications.

[38]  M. Correia,et al.  Microsomal cytochrome P450-mediated liver and brain anandamide metabolism. , 1995, Biochemical pharmacology.

[39]  Z. Vogel,et al.  Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. , 1995, Biochemical pharmacology.

[40]  D. Piomelli,et al.  Anandamide Amidohydrolase Activity in Rat Brain Microsomes , 1995, The Journal of Biological Chemistry.

[41]  N. Matsuki,et al.  Lipoxygenase-catalyzed oxygenation of arachidonylethanolamide, a cannabinoid receptor agonist. , 1995, Biochimica et biophysica acta.

[42]  K. Rice,et al.  Cannabinoid receptor binding and agonist activity of amides and esters of arachidonic acid. , 1994, Molecular pharmacology.

[43]  M. Correia,et al.  The effect of cannabidiol on mouse hepatic microsomal cytochrome P450-dependent anandamide metabolism. , 1993, Biochemical and biophysical research communications.

[44]  D. Deutsch,et al.  Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist. , 1993, Biochemical pharmacology.

[45]  D. Gibson,et al.  Isolation and structure of a brain constituent that binds to the cannabinoid receptor. , 1992, Science.

[46]  D. Steinberg,et al.  A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[47]  D. Yang,et al.  Oxygenation of phosphatidylcholine by human polymorphonuclear leukocyte 15-lipoxygenase. , 1985, Biochemical and biophysical research communications.

[48]  M. Caton,et al.  Prostaglandins and thromboxanes. , 1979, Progress in medicinal chemistry.

[49]  S. Rapoport,et al.  A lipoxygenase in rabbit reticulocytes which attacks phospholipids and intact mitochondria , 1975, FEBS letters.

[50]  M. Hamberg,et al.  Detection and isolation of an endoperoxide intermediate in prostaglandin biosynthesis. , 1973, Proceedings of the National Academy of Sciences of the United States of America.

[51]  D. V. van Dorp,et al.  The action of prostaglandin synthetase on 2-arachidonyl-lecithin. , 1968, Biochimica et biophysica acta.

[52]  B. Samuelsson,et al.  Phospholipid precursors of prostaglandins. , 1968, Biochimica et biophysica acta.

[53]  R. Garavito,et al.  Cyclooxygenases: structural, cellular, and molecular biology. , 2000, Annual review of biochemistry.

[54]  J. Vane,et al.  Cyclooxygenases 1 and 2. , 1998, Annual review of pharmacology and toxicology.

[55]  N. Ueda,et al.  Oxygenation of arachidonylethanolamide (anandamide) by lipoxygenases. , 1995, Advances in prostaglandin, thromboxane, and leukotriene research.

[56]  E. Granström Metabolism of Prostaglandins , 1977 .